Thomas Penn

Tom has over 30 years of experience in starting, managing, and financing high growth companies primarily in the Mid-Atlantic region. Before joining MVP Capital Partners as a Partner, he served as a Partner at Boston Millennia Partners, a $600 million venture capital firm, where he focused largely on life science investments.

At MVP, a private equity firm in Radnor, PA he has served on numerous company boards including Andrews International, Coffin Turbo Pump, ExpertPlan, ANI Pharmaceuticals (NASDAQ:ANIP), GCA Services, MCMC, Northern Contours, and Implex among others. Mr. Penn works in a variety of industries but has special expertise in healthcare and the life sciences.

From 1994 to 1998, Mr. Penn was President and CEO of Tektagen, Inc., a leading contract services firm serving the biotechnology and pharmaceutical industries. Tektagen was successfully sold to Charles River Laboratories, Inc. (NYSE: CRL) in 1998. Prior to Tektagen, Mr. Penn was President of Independence Ventures, Inc., a firm that specialized in starting and building high-potential, technology-based companies. Earlier in his career he held several positions in industry and venture capital.

Tom is the founder of the Entrepreneurs’ Forum of Greater Philadelphia and the originator of the Philadelphia 100 project. He is past President of the Pennsylvania Biotechnology Association and also served as Co-Chair of Pennsylvania’s Technology 21 Biotechnology network.

Tom is a graduate of the Massachusetts Institute of Technology (Metallurgy and Material Science and Industrial Management), the Stanford University Graduate School of Business, and the University of Pennsylvania Law School.